105 related articles for article (PubMed ID: 17476595)
41. Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer.
Kim YJ; Kim MA; Im SA; Kim TM; Kim DW; Yang HK; Heo DS; Lee KU; Choe KJ; Kim NK; Kim TY; Kim WH; Bang YJ
Cancer Invest; 2008 Mar; 26(2):152-8. PubMed ID: 18259945
[TBL] [Abstract][Full Text] [Related]
42. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
[TBL] [Abstract][Full Text] [Related]
43. Changing pattern of postoperative body weight and its association with recurrence and survival after curative resection for gastric cancer.
Lee SE; Lee JH; Ryu KW; Nam B; Kim CG; Park SR; Kook MC; Kim YW
Hepatogastroenterology; 2012; 59(114):430-5. PubMed ID: 22353511
[TBL] [Abstract][Full Text] [Related]
44. Early gastric cancer: a single-institution experience on 60 cases.
Sigon R; Canzonieri V; Rossi C
Suppl Tumori; 2003; 2(5):S23-6. PubMed ID: 12914385
[TBL] [Abstract][Full Text] [Related]
45. Impact of the Surveillance Interval on the Survival of Patients Who Undergo Curative Surgery for Gastric Cancer.
Park CH; Park JC; Chung H; Shin SK; Lee SK; Cheong JH; Hyung WJ; Lee YC; Noh SH; Kim CB
Ann Surg Oncol; 2016 Feb; 23(2):539-45. PubMed ID: 26424325
[TBL] [Abstract][Full Text] [Related]
46. Limited gastrectomy with dissection of sentinel node stations for early gastric cancer with negative sentinel node biopsy.
Ichikura T; Sugasawa H; Sakamoto N; Yaguchi Y; Tsujimoto H; Ono S
Ann Surg; 2009 Jun; 249(6):942-7. PubMed ID: 19474686
[TBL] [Abstract][Full Text] [Related]
47. Recurrence of gastric cancer in patients who are disease-free for more than 5 years after primary resection.
Lee JH; Kim HI; Kim MG; Ha TK; Jung MS; Kwon SJ
Surgery; 2016 Apr; 159(4):1090-8. PubMed ID: 26747230
[TBL] [Abstract][Full Text] [Related]
48. CD133 expression is correlated with chemoresistance and early recurrence of gastric cancer.
Lee HH; Seo KJ; An CH; Kim JS; Jeon HM
J Surg Oncol; 2012 Dec; 106(8):999-1004. PubMed ID: 22674531
[TBL] [Abstract][Full Text] [Related]
49. Expression of BMP-7 in human gastric cancer and its clinical significance.
Aoki M; Ishigami S; Uenosono Y; Arigami T; Uchikado Y; Kita Y; Kurahara H; Matsumoto M; Ueno S; Natsugoe S
Br J Cancer; 2011 Feb; 104(4):714-8. PubMed ID: 21224856
[TBL] [Abstract][Full Text] [Related]
50. Recurrence after curative resection of early gastric cancer.
Youn HG; An JY; Choi MG; Noh JH; Sohn TS; Kim S
Ann Surg Oncol; 2010 Feb; 17(2):448-54. PubMed ID: 19904573
[TBL] [Abstract][Full Text] [Related]
51. Value of intensive follow-up of patients after curative surgery for gastric carcinoma.
Tan IT; So BY
J Surg Oncol; 2007 Nov; 96(6):503-6. PubMed ID: 17680634
[TBL] [Abstract][Full Text] [Related]
52. Comparison of outcomes after laparoscopy-assisted and open total gastrectomy for early gastric cancer.
Lee JH; Nam BH; Ryu KW; Ryu SY; Park YK; Kim S; Kim YW
Br J Surg; 2015 Nov; 102(12):1500-5. PubMed ID: 26398912
[TBL] [Abstract][Full Text] [Related]
53. [The role of tumor markers in diagnostics of gastric cancer metastases. Part II: postoperative monitoring].
Kurygin AA; Maĭstrenko NA; Khrykov GN; Beliak NP
Vestn Khir Im I I Grek; 2009; 168(5):13-6. PubMed ID: 20020621
[TBL] [Abstract][Full Text] [Related]
54. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study.
Roukos DH; Lorenz M; Karakostas K; Paraschou P; Batsis C; Kappas AM
Br J Cancer; 2001 Jun; 84(12):1602-9. PubMed ID: 11401312
[TBL] [Abstract][Full Text] [Related]
55. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin.
Chan AO; Chu KM; Lam SK; Cheung KL; Law S; Kwok KF; Wong WM; Yuen MF; Wong BC
Cancer; 2005 Aug; 104(4):740-6. PubMed ID: 15991243
[TBL] [Abstract][Full Text] [Related]
56. Clinicopathological features, surgical management, and disease outcome of perforated gastric cancer.
Jwo SC; Chien RN; Chao TC; Chen HY; Lin CY
J Surg Oncol; 2005 Sep; 91(4):219-25. PubMed ID: 16121341
[TBL] [Abstract][Full Text] [Related]
57. The prognostic value of postoperative tumor marker conversion for gastric cancer.
Noh J; Park KB; Kwon OK
Korean J Clin Oncol; 2020 Dec; 16(2):119-126. PubMed ID: 36945721
[TBL] [Abstract][Full Text] [Related]
58. A computational method for prediction of excretory proteins and application to identification of gastric cancer markers in urine.
Hong CS; Cui J; Ni Z; Su Y; Puett D; Li F; Xu Y
PLoS One; 2011 Feb; 6(2):e16875. PubMed ID: 21365014
[TBL] [Abstract][Full Text] [Related]
59. Clinical usefulness of circulating tumor markers.
Filella X; Rodríguez-Garcia M; Fernández-Galán E
Clin Chem Lab Med; 2023 Apr; 61(5):895-905. PubMed ID: 36394981
[TBL] [Abstract][Full Text] [Related]
60. [False negative and false positive results of tumor markers: their limitation in clinical practice. Clinical applications of CA-125].
Jiménez Lacave A; Allende Monclús M
Rev Clin Esp; 2001 Dec; 201(12):715-7. PubMed ID: 11835885
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
